Erratum to: Breast Cancer Res Treat (2012) 136:717–727 DOI 10.1007/s10549-012-2260-9
In the original publication, the authors stated that “high levels of IGF1R and pIGF1R were associated with higher IC50 values for NVP-AEW541, with p values approaching statistical significance (IGF1R: P = 0.053; pIGF1R: P = 0.078)”. This statement should read as “high levels of IGF1R and pIGF1R were associated with lower IC50 values for NVP-AEW541”. Consequently high IGF1R and pIGF1R levels are weakly predictive of sensitivity to NVP-AEW541. These updated data have no significant effect on any of the other statistical correlations listed in the article.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found under doi:10.1007/s10549-012-2260-9.
Rights and permissions
About this article
Cite this article
Browne, B.C., Eustace, A.J., Kennedy, S. et al. Erratum to: Evaluation of IGF1R and phosphorylated IGF1R as targets in HER2-positive breast cancer cell lines and tumours. Breast Cancer Res Treat 148, 697 (2014). https://doi.org/10.1007/s10549-014-3176-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-014-3176-3